$2 here we come...., page-178

nice result
strong positive commentary
i dont really understand why the tone of the myx commentary around generics is so positive whenteva/mylan/ novartis were all negative.

anyway the business has stabilised and there are cleargrowth drivers ahead so im happy to acknowledge that this result and the outlook was better than i expected and the sp has risen accordingly so congrats to those that bought early and held strong.

ill stay on the sidelines as im still uneasy about the us generics environment amd the myx result in generics was not great and there was no clear forward guidance numbers.

i suspect it will grind higher now but the low hanging fruit has been picked by the brave at 60-80c.